市場調查報告書
商品編碼
1182192
2022-2029 年全球緩釋輔料市場規模、研究和預測、按產品、給藥途徑、技術和地區分析Global Sustained Release Excipients Market Size study & Forecast, by Product by Route of Administration, by Technology and Regional Analysis, 2022-2029 |
2021 年全球緩釋輔料市場價值約 11.9 億美元,預計在 2022-2029 年預測期內以超過 8.22% 的健康增長率增長。
緩釋賦形劑是設計用於在特定時間段內緩慢釋放藥物的劑型,有助於保持一致的藥物濃度,同時最大限度地減少副作用。 兒科和老年人對緩釋劑型的需求不斷增長,緩釋賦形劑相對於傳統劑型的優勢越來越大,這些都成為全球市場需求的主要催化劑。
口服給藥技術的發展一直強調提高藥物治療能力以及生物利用度和患者依從性。
例如,2021 年 9 月在美國國家生物技術信息中心 (NCBI) 發表的一篇論文描述了胃滯留給藥技術在上消化道維持劑型的潛在用途。因此,這些具有緩釋方法的技術將通過減少給藥頻率提供更好的患者依從性和治療效果,從而加速全球市場的市場需求。 此外,對抗生素耐藥性的日益關注和由於配方特性而增加的可接受性也是未來幾年增加市場機會的因素。 然而,由於劑量傾銷和對更高劑量 API 的需求不斷增長,潛在的藥物毒性與潛在的藥物毒性有關,從而限制了整個 2022-2029 年預測期內的市場增長。
研究全球控釋輔料市場的主要區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 在北美,專利到期、仿製藥繼續進入以及研發投資增加帶來了盈利優勢。 另一方面,預計亞太地區在預測期內將顯著增長。 未來將加速市場增長的因素包括各種傳染病的增加、對高效治療藥物的需求不斷增長以及新生產設施的建立。
本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模,並預測未來幾年的市場規模。 該報告旨在包括被調查國家工業的定性和定量方面。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和產品供應的深入分析。
Global Sustained Release Excipients Market is valued at approximately USD 1.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.22% over the forecast period 2022-2029. Sustained release excipients are a dosage form that is designed to release a drug slowly during a specific period to help in maintaining a constant drug concentration with minimum side effects. The growing need for pediatric and geriatric sustained release dosage forms and rising benefits of sustained release excipients compared to conventional dosage forms are acting as a major catalyzing factor for the market demand around the world.
The rising emphasis on the development of oral drug delivery technologies is because of improving drug therapeutic competence, along with bioavailability and patient compliance.
For instance, an article published in the National Center for Biotechnology Information (NCBI) on September 2021 stated the potential use of gastro retentive drug delivery techniques that maintain dose forms in the upper gastrointestinal tract. Thus, these technologies with sustained-release approaches offer better patient compliance and therapeutic effectiveness by decreasing dosing frequency, which, in turn, fuels the market demand in the global market. Furthermore, the growing focus on antibiotic resistance, as well as increasing acceptance owing to the nature of dosage forms are further factors that are leveraging the market opportunities in the forthcoming years. However, the chances of drug toxicity are associated due to dose dumping and the growing need for the high dose of API is restricting the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Sustained Release Excipients Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the patent expirations and successive entry of generics, along with the growing investment in R&D activities. Whereas, the Asia Pacific is expected to grow significantly during the forecast period. Factors such as the increasing prevalence of various infectious diseases, the growing need for highly effective therapeutics, as well as rising establishment of production facilities, are burgeoning the market growth in the forecasting years.
Major market players included in this report are:
BASF SE
International Flavors & Fragrances, Inc.
Ashland Global
Evonik Industries
Croda International Plc
Gattefosse
Merck KGaA
Pfizer, Inc.
Sun Pharmaceutical Industries Ltd.
Mayne Pharma Group Limited
Recent Developments in the Market:
Global Sustained Release Excipients Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Route of Administration, Technology, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Gelatin
Polymers
Minerals
Sugars
Others
By Route of Administration:
Oral
Intramuscular
Subcutaneous
Transdermal
Intravenous
Others
By Technology:
Targeted Delivery
Microencapsulation
Wurster Technique
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable